GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (STU:S1R) » Definitions » Construction In Progress

Shanghai Pharmaceuticals Holding Co (STU:S1R) Construction In Progress : €294 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Construction In Progress?

Shanghai Pharmaceuticals Holding Co's quarterly construction in progress declined from Sep. 2024 (€499 Mil) to Dec. 2024 (€282 Mil) but then increased from Dec. 2024 (€282 Mil) to Mar. 2025 (€294 Mil).

Shanghai Pharmaceuticals Holding Co's annual construction in progress increased from Dec. 2022 (€376 Mil) to Dec. 2023 (€458 Mil) but then declined from Dec. 2023 (€458 Mil) to Dec. 2024 (€282 Mil).


Shanghai Pharmaceuticals Holding Co Construction In Progress Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Construction In Progress Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 218.37 404.91 376.07 458.44 281.84

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 537.03 559.07 498.70 281.84 294.00

Shanghai Pharmaceuticals Holding Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Shanghai Pharmaceuticals Holding Co Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2024, medical distribution is the largest segment, accounting for 91.3% of total revenue. It also has coverage of 31 provinces and cities nationwide.

Shanghai Pharmaceuticals Holding Co Headlines

No Headlines